Cargando…

Peripheral blood markers predict immunotherapeutic efficacy in patients with advanced non-small cell lung cancer: A multicenter study

This study aims to investigate the prognostic impact of peripheral blood markers in patients with advanced non-small cell lung cancer (NSCLC) undergoing immunotherapy. In the current multicenter study, 157 advanced NSCLC cases treated by immunotherapy at three institutions were included. Biochemical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shuai, Zhao, Liuyuan, Zhou, Guohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630578/ https://www.ncbi.nlm.nih.gov/pubmed/36338995 http://dx.doi.org/10.3389/fgene.2022.1016085

Ejemplares similares

FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy
por: Deng, Jiehua, et al.
Publicado: (2022)

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy
por: Lin, Zhengjun, et al.
Publicado: (2022)

Screening and identifying a novel M-MDSCs-related gene signature for predicting prognostic risk and immunotherapeutic responses in patients with lung adenocarcinoma
por: Wang, Geng-Chong, et al.
Publicado: (2023)

Tumor Microenvironment-Mediated Immune Profiles Characterized by Distinct Survival Outcome and Immunotherapeutic Efficacy in Breast Cancer
por: Xu, Lijun, et al.
Publicado: (2022)

Cuproptosis scoring model predicts overall survival and assists in immunotherapeutic decision making in pancreatic carcinoma
por: Liu, Tijun, et al.
Publicado: (2022)

Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma
por: Ma, Tianming, et al.
Publicado: (2021)

An Immune-Related Gene Signature Can Predict Clinical Outcomes and Immunotherapeutic Response in Oral Squamous Cell Carcinoma
por: Zhang, Liyuan, et al.
Publicado: (2022)

Characteristics of Genomic Alterations in Pericardial Effusion of Advanced Non-small Cell Lung Cancer
por: He, Jiaxue, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of ALKBH7
por: Chen, Kaijie, et al.
Publicado: (2022)

Comprehensive analysis of the prognostic and immunotherapeutic implications of STAT family members in human colorectal cancer
por: Li, Dingchang, et al.
Publicado: (2022)

Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules
por: Alotaibi, Faizah
Publicado: (2023)

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2)
por: Jiang, Zhong-Hui, et al.
Publicado: (2022)

Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors
por: Peng, Lihong, et al.
Publicado: (2020)

Inflammation‐nutritional markers of peripheral blood could predict survival in advanced non‐small‐cell lung cancer patients treated with PD‐1 inhibitors
por: Pu, Dan, et al.
Publicado: (2021)

Immunotherapeutic Advancements for Glioblastoma
por: Ampie, Leonel, et al.
Publicado: (2015)

Immunotherapeutic Advances for NSCLC
por: Massafra, Marco, et al.
Publicado: (2021)

F2RL3 Methylation in the Peripheral Blood as a Potential Marker for the Detection of Coronary Heart Disease: A Case-Control Study
por: Zhao, Xiaojing, et al.
Publicado: (2022)

Be careful with small supernumerary marker chromosomes!
por: Rodríguez, Laura
Publicado: (2023)

Angiogenic Factor-Based Signature Predicts Prognosis and Immunotherapy Response in Non-Small-Cell Lung Cancer
por: Gu, Xinpei, et al.
Publicado: (2022)

An autophagy-associated lncRNAs model for predicting the survival in non-small cell lung cancer patients
por: Hu, Jing, et al.
Publicado: (2022)

Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer
por: Zhou, Xuan, et al.
Publicado: (2022)

Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer
por: Miao, Kang, et al.
Publicado: (2022)

Potentials of Non-Invasive (18)F-FDG PET/CT in Immunotherapy Prediction for Non–Small Cell Lung Cancer
por: Liao, Xuhe, et al.
Publicado: (2022)

Identification of Immune-Related Biomarkers for Sciatica in Peripheral Blood
por: Jin, Xin, et al.
Publicado: (2021)

Immunogenic cell death mediation patterns reveal novel paradigm for characterizing the immune microenvironment and immunotherapeutic responses in bladder cancer
por: Fu, Jialei, et al.
Publicado: (2022)

Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk
por: He, Bing-Xi, et al.
Publicado: (2022)

Whole-Exome Sequencing on Circulating Tumor Cells Explores Platinum-Drug Resistance Mutations in Advanced Non-small Cell Lung Cancer
por: Chang, Yuanyuan, et al.
Publicado: (2021)

Conversion of specific lncRNAs to biomarkers in exhaled breath condensate samples of patients with advanced stage non-small-cell lung cancer
por: Tetik Vardarlı, Aslı, et al.
Publicado: (2023)

EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma
por: Bai, Hua, et al.
Publicado: (2020)

Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures
por: Wei, Feifei, et al.
Publicado: (2023)

Corrigendum: Peripheral blood lymphocyte subsets predict the efficacy of immune checkpoint inhibitors in non– small cell lung cancer
por: Miao, Kang, et al.
Publicado: (2022)

Clinical value of peripheral blood circulating tumor DNA in predicting the efficacy of immunotherapy for non-small cell lung cancer
por: Wang, Jing, et al.
Publicado: (2023)

Immunotherapeutic advances in gastrointestinal malignancies
por: Rao, Devika, et al.
Publicado: (2019)

Epigenetic Biomarkers Screening of Non-Coding RNA and DNA Methylation Based on Peripheral Blood Monocytes in Smokers
por: Huang, Xiaowei, et al.
Publicado: (2022)

Prognostic markers of ferroptosis-related long non-coding RNA in lung adenocarcinomas
por: Mao, Kaimin, et al.
Publicado: (2023)

Comprehensive Assessment of Serum hsa_circ_0070354 as a Novel Diagnostic and Predictive Biomarker in Non-small Cell Lung Cancer
por: Huang, Yuejiao, et al.
Publicado: (2022)

Pretreatment Thoracic CT Radiomic Features to Predict Brain Metastases in Patients With ALK-Rearranged Non-Small Cell Lung Cancer
por: Wang, Hua, et al.
Publicado: (2022)

Signature based on RNA-binding protein-related genes for predicting prognosis and guiding therapy in non-small cell lung cancer
por: Miao, Ti-Wei, et al.
Publicado: (2022)

Morchella esculenta cultivation in fallow paddy fields and drylands affects the diversity of soil bacteria and soil chemical properties
por: Duan, Mingzheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ra3qg6fhloitec36pjvjt1cjj7